Axcel has agreed to sell European Sperm Bank to Perwyn, positioning ESB for further growth and market expansion in the fertility services industry.
Information on the Target
European Sperm Bank (ESB), headquartered in Copenhagen, Denmark, is a preeminent provider of donor sperm and related reproductive services, catering to women and couples across more than 90 countries worldwide. Established in 2004, ESB has cultivated a diverse and extensive donor base through rigorous testing and recruitment, adhering to the highest industry standards. Over the years, the bank has successfully assisted thousands of individuals and couples in realizing their aspiration of starting a family.
Since Axcel's acquisition of ESB in 2019, the firm has focused on enhancing the company’s operational framework while upholding the core values of quality, ethics, compliance, and sustainability. Under this stewardship, ESB has made considerable investments in strengthening its organizational structure and digital footprint, while also expanding its network of donor sites and laboratories, particularly in Denmark and the Netherlands. These initiatives have culminated in notable growth and a fortified market presence.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Denmark
The fertility services industry in Denmark has evolved significantly, becoming a global hub for reproductive healthcare. Known for its liberal policies surrounding assisted reproduction, Denmark attracts a diverse international clientele see
Similar Deals
Nordic Capital and Permira → Bavarian Nordic
2025
Perwyn
invested in
European Sperm Bank
in 2022
in a Buyout deal